Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. Cohen JA, Khatri B, Barkhof F, Comi G, Hartung H-P, Montalban X, Pelletier J, Stites T, Ritter S, von Rosenstiel P, et al. J Neurol Neurosurg Psychiatry. 2015 Jun 25. PMID: 26111826. Abstract CommentRecommendBookmarkWatch